Melanoma, artificial reproductive therapy and pregnancy; is there an increased risk of recurrence?

Melanoma, artificial reproductive therapy and pregnancy; is there an increased risk of recurrence? - Melanoma, ART and pregnancy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41738

Enrollment

1230

Registered

2016-08-25

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma skincancer

Interventions

Artificial Reproductive Therapy

Melanoma

Pregnancy

Recurrence rate

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age between 18 and 45 years at time of the diagnosis melanoma. - Stage I or II melanoma in the medical history.

Exclusion criteria

Exclusion criteria: - Age 45 years at diagnosis. - Melanoma in situ - Inability to read and understand the Dutch language.

Design outcomes

Primary

Measure	Time frame
- Recurrent rate of melanoma after ART - Recurrent rate of melanoma after ongoing pregnancy. - Recurrent rate of melanoma after ongoing pregnancy after ART.	—

Secondary

Measure	Time frame
- The amount of advice and education on hormonal therapy after melanoma - Anxiety and/or stress due to hormonal therapie or pregnancy after melanoma	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)